|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/06 | |
| A61K 9/00 | |||
| A61K 47/36 | |||
| A61K 38/17 | |||
| A61K 38/19 | |||
| A61K 39/395 |
| (11) | Number of the document | 3506884 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17765524.8 |
| Date of filing the European patent application | 2017-08-30 | |
| (97) | Date of publication of the European application | 2019-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/049424 |
| Date | 2017-08-30 |
| (87) | Number | WO 2018/045058 |
| Date | 2018-03-08 |
| (30) | Number | Date | Country code |
| 201662381456 P | 2016-08-30 | US | |
| 201762486814 P | 2017-04-18 | US | |
| 201762501464 P | 2017-05-04 | US |
| (72) |
GOLDBERG, Michael, Solomon, US
PARK, Chun, Gwon, US
|
| (73) |
Dana-Farber Cancer Institute, Inc.,
450 Brookline Avenue, Boston, MA 02215,
US
|
| (54) | DRUG DELIVERY COMPOSITIONS AND USES THEREOF |
| DRUG DELIVERY COMPOSITIONS AND USES THEREOF |